The Online Books Page

Biological products -- United States -- Legislation

See also what's at your library, or elsewhere.

• Biological products -- United States
• Legislation

• NHLI's blood resource studies. (For sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington, 1972), by National Blood Resource Program (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah. (U.S. G.P.O. :, 2008), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)

• Establishments and products licensed under section 351 of the Public Health Service Act (The Administration, 1971), by United States. Food and Drug Administration. Bureau of Biologics, United States Food and Drug Administration, and National Institutes of Health (U.S.). Division of Biologics Standards (page images at HathiTrust)

• Establishments and products licensed under section 351 of the Public Health Service Act (The Administration, 1971), by United States. Food and Drug Administration. Bureau of Biologics, United States Food and Drug Administration, and National Institutes of Health (U.S.). Division of Biologics Standards (page images at HathiTrust)

• Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007. (U.S. G.P.O. :, 2008), by United States House Committee on Oversight and Government Reform (page images at HathiTrust)
• Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• The Right choice : minority college & university program. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1991), by Center for Biologics Evaluation and Research (U.S.) (page images at HathiTrust)

• Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military (2002), ed. by Stanley M. Lemon, Susan Thaul, Salem Fisseha, and Heather C. O'Maonaigh (page images with commentary at NAP)
• FACA, conflicts of interest and vaccine development--preserving the integrity of the process (U.S. G.P.O. :, 2001), by United State House Committee on Government Reform (page images at HathiTrust)

• Barriers to immunization, vaccines for children (The Office ;, 1995), by Kwai-Cheung Chan, United States. Congress. Senate. Committee on Finance, and United States General Accounting Office (page images at HathiTrust)

• Problems of vaccine supply and delivery : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Second Congress, first session, special hearing. (U.S. G.P.O. :, 1991), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)

• Vaccine Safety Forum: Summaries of Two Workshops (1997), by Institute of Medicine (U.S.) (page images with commentary at NAP)
• The vaccine injury compensation program : addressing needs and improving practices : sixth report (U.S. G.P.O., 2000), by United State House Committee on Government Reform (page images at HathiTrust)
• Vaccines, finding the balance between public safety and personal choice (U.S. G.P.O. :, 2000), by United State House Committee on Government Reform (page images at HathiTrust)
• Force protection or false security (U.S. G.P.O. :, 2000), by United State House Committee on Government Reform (page images at HathiTrust)

• Hepatitis B vaccine : helping or hurting public health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 18, 1999. (U.S. G.P.O. :, 2000), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)

• The continuing oversight of the National Vaccine Injury Compensation Program : hearing before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, September 18, 2002. (U.S. G.P.O. :, 2003), by United State House Committee on Government Reform (page images at HathiTrust)
• The vaccine injury compensation program : addressing needs and improving practices : sixth report (U.S. G.P.O., 2000), by United State House Committee on Government Reform (page images at HathiTrust)
• Vaccines, finding the balance between public safety and personal choice (U.S. G.P.O. :, 2000), by United State House Committee on Government Reform (page images at HathiTrust)
• Compensating vaccine injuries : are reforms needed? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, September 28, 1999. (U.S. G.P.O. :, 2000), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
• The National Vaccine Injury Program : is it working as Congress intended? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, November 1 and December 12, 2001. (U.S. G.P.O. :, 2002), by United State House Committee on Government Reform (page images at HathiTrust)

• Financing Vaccines in the 21st Century: Assuring Access and Availability (c2004), by Institute of Medicine (U.S.) Board on Health Care Services (page images with commentary at NAP)

• Vaccine Supply and Innovation (1985), by Institute of Medicine (U.S.) (page images with commentary at NAP)
• Biotechnology vaccine development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 13, 1985. (U.S. G.P.O., 1985), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Vaccine injury compensation hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 1780, H.R. 4777, and H.R. 5184 ... July 25, 1986. (U.S. G.P.O., 1987), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Revenue exceeds current need for paying claims (The Office, 2000), by United States General Accounting Office (page images at HathiTrust)
• Are childhood vaccine supplies adequate? (U.S. G.P.O. :, 2003), by Education United States. Congress. Senate. Committee on Health (page images at HathiTrust)
• The administration's flu vaccine program : health, safety, and distribution : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, first session, September 29, 2009. (U.S. G.P.O. :, 2009), by United States House Committee on Oversight and Government Reform (page images at HathiTrust)
• Vaccine injury compensation : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 1780, H.R. 4777, and H.R. 5184 ... July 25, 1986. (U.S. G.P.O. :, 1987), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Biological threats : is the current U.S. vaccine production system prepared? : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, first session, special hearing, August 21, 2009, Pittsburgh, PA. (U.S. G.P.O. :, 2010), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
• USDA licensing of a genetically altered veterinary vaccine : joint hearing before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology and the Subcommittee on Department Operations, Research, and Foreign Agriculture of the Committee on Agriculture, House of Representatives, Ninety-ninth Congress, second session, April 29, 1986. (U.S. G.P.O. :, 1986), by United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight and Research United States. Congress. House. Committee on Agriculture. Subcommittee on Department Operations (page images at HathiTrust)
• What is causing the current shortage in childhood vaccines? (U.S. G.P.O. :, 2002), by United States Senate Committee on Governmental Affairs (page images at HathiTrust)
• Problems of vaccine supply and delivery : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Second Congress, first session, special hearing. (U.S. G.P.O. :, 1991), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
• Program challenged to settle claims quickly and easily (The Office, 1999), by United States General Accounting Office and United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)

• Biodefense and Pandemic Vaccine and Drug Development Act of 2006 : report (to accompany H.R. 5533) (including cost estimate of the Congressional Budget Office). (U.S. G.P.O. :, 2006), by United States House. Committee on Energy and Commerce (page images at HathiTrust)

• Oversight of immunization cost : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session, on to review federal and state expenditures for the purchase of children's vaccines, July 22, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight (page images at HathiTrust)

• Biotechnology vaccine development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 13, 1985. (U.S. G.P.O., 1985), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Biotechnology : vaccine development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 13, 1985. (U.S. G.P.O., 1985), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Assessing the national pandemic flu preparedness plan : hearing before the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, November 8, 2005. (U.S. G.P.O. :, 2005), by United States House. Committee on Energy and Commerce (page images at HathiTrust)
• Linking bioterrorism threats and countermeasure procurement to enhance terrorism preparedness (U.S. G.P.O. :, 2007), by Science United States. Congress. House. Committee on Homeland Security. Subcommittee on Emergency Preparedness (page images at HathiTrust)
• Biological warfare defense vaccine research and development program : hearing before the Subcommitttee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, October 23, 2001. (U.S. G.P.O. :, 2002), by Veterans Affairs United States. Congress. House. Committee on Government Reform. Subcommittee on National Security (page images at HathiTrust)

• Veterinary biologics : use and regulation. (U.S. Dept. of Agriculture, Animal and Plant Health Inspection Service, 2002), by United States. Animal and Plant Health Inspection Service (page images at HathiTrust)
• Care and use of veterinary biologics : veterinarian's check list. (Veterinary Biologics Division, Agricultural Research Service, U.S. Dept. of Agriculture, 1968), by United States. Agricultural Research Service. Veterinary Biologics Division (page images at HathiTrust)

• The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009. (U.S. G.P.O. :, 2009), by United States. Congress. House. Committee on Science and Technology (2007). Subcommittee on Technology and Innovation (page images at HathiTrust)

• Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009. (U.S. G.P.O. :, 2010), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy (page images at HathiTrust)
• Emerging health care issues : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009. (U.S. G.P.O. :, 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
• Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012. (Washington : U.S. Government Printing Office, 2013., 2013), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)

• Food and Drug Administration quarterly activities report (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1973), by United States. Food and Drug Administration. Program Information and Analysis Group (page images at HathiTrust)
• Preamble compilation : biological products, March 1936-March 1978. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration ;, 1981), by United States Food and Drug Administration (page images at HathiTrust)
• Summary of FDA activities. (Dept. of Health, Education and Welfare, Food and Drug Administration., between 1000 and 1999), by United States Food and Drug Administration (page images at HathiTrust)
• Biological products : Public Health Service regulations, title 42, part 73. (Available from the Division of Biologics Standards, National Institutes of Health, Bethesda, Md., 1965), by United States Public Health Service and National Institutes of Health (U.S.). Division of Biologics Standards (page images at HathiTrust)

More items available under broader and related terms at left.